Browse drugs

…osis rates. The current study evaluates in-stent stenosis after Surpass Elite implantation in an effort to provide insight into its safety an…

…lopramide (10 mg), ondansetron (4 mg), droperidol (2.5 mg), and diphenhydramine (25 mg). Magnetic resonance imaging (MRI) of the brain demonstr…

…cause difficulty in lesion access, but does not obviate further ethanol endovascular treatment.Disclosures W. Yakes: None.…

…ers in the straight sinus in 2, combination stent-retriever and HiPoint 88 in 3, initial Sofia 6 F Plus passes prior to HiPoint88 in 1 pat…

…d right ascending cerebellar artery pathway. After unsuccessful Onyx embolization, we attempt to remove the Apollo microcatheter. Ho…

…mRS (3 [IQR 6-1], p=<0.001) for shorter clots, while the use of CAPTIVE correlated with lower mRS scores for longer clots (figure 2).Co…

…emonstrated a positive long-term treatment effect of MMAE using TRUFILL n-BCA versus SOC for reduction in requirement for re-operation on cSD…

…on in preclinical models.Immunosuppression using agents such as cyclosporine A (CsA) is a significant confounding variable in preclinical expe…

…preclinical and early clinical studies demonstrate that in situ PBM delivery is feasible and safe for patients treated with flow di…

…mFI-5 achieving the highest performance (AUC 0.92), followed by RAI-rev (AUC 0.89), with consistent ranking in random forest variable i…

…ntation rate (ESR) from baseline to 72 hours was greater in the dexamethasone group, absolute ESR values at 72 hours did not differ consisten…

…t (from the previous year). Incidence was further stratified by PrEP use in 2022/2023.Results The number of HIV-negative GBMSM atten…